Binding of a valproate metabolite to the trifunctional protein of fatty acid oxidation

Abstract

The anti-convulsant drug valproate causes hepatic failure in a small percentage of patients. We now report that the valproate metabolite 2,4-dien-valproate binds (IC 50 = 42 μM) to the α-subunit of the trifunctional protein responsible for the second and third steps in the mitochondrial β-oxidation of fatty acids. Binding of valproate itself, or of the metabolites 2-envalproate, 4-en-valproate or 3-hydroxy-4-en-valproate, is considerably weaker. We conclude that valproate-induced hepatotoxicity may be due in part to the reversible binding of the valproate metabolite 2,4-dien-valproate or its CoA ester to the α-subunit of the trifunctional protein with consequent inhibition of fatty acid oxidation.